Other Ingredients: Purified Water, Vegetable Glycerin, Malic Acid, Citric Acid, Natural Fruit Extracts and Flavors, Potassium Sorbate (as preservative) and Lemon (Citrus limon) Oil
A phase 2 trial of exenatide in treating AD showed that patients displayed reduced amyloid- 42 concentrations, the abnormal accumulations that are a primary driver of AD
Rare mutations in the SLC22A5 gene can cause a genetic condition called primary carnitine deficiency, which is usually discovered in infancy because it affects brain function, muscle function, and blood glucose levels
Published in 1993, this testing was overseen by Michael Nauck, a physician at the University of Gttingen in collaboration with Creutzfeldt, Holst and other colleagues